No. Signed TCV is the tenant's option, not the landlord's receivable. Nscale's prospectus shows active and contracted TCV of $103.4 billion as of 2026-08-31, of which $2.6 billion is active, or 2.5% (self-computed); first-half revenue was $140 million against a net loss of $1.02 billion.
Consensus (Bloomberg/Quartz/Axios) puts the risk in Nscale's customer concentration; the diary puts it in the asymmetric risk allocation of the contracts. 'Up to' is conditional on delivery and availability targets, CoreWeave's backlog uses the same wording, and TCV across the neocloud sector is option value.
Nscale S-1 (2026-09-18): Microsoft up to $43.8 billion and Anthropic up to $44.6 billion, together about 85% (self-computed; the S-1 does not state it); weighted-average customer prepayment 23%, Anthropic zero. NVIDIA official release (10 August): GPU residual-value support of up to 25% per project, approved deal by deal; the two disclosed CoreWeave and Nebius financings are collateralized by contracted customer cash flows.
For founders: if you sell compute, do not sign with prepayment below one-fifth; lock the contract before buying cards, and do not raise financing on GPU residual value. For investors: move the valuation anchor from signed TCV to active TCV plus TCV covered by closed financing; price compute structured products that do not disclose advance rates and residual assumptions as unsecured.